Baird; Ian
Patent Applications and Registrations
Patent applications and USPTO patent grants for Baird; Ian.The latest application filed is for "chemokine receptor binding heterocyclic compounds with enhanced efficacy".
- Baird; Ian - West Abbotsford CA
- BAIRD; Ian - Abbotsford CA
- Baird, Ian - Vancouver CA
| Patent | Date |
|---|---|
| CXCR4 chemokine receptor binding compounds Grant 7,863,293 - Bridger , et al. January 4, 2 | 2011-01-04 |
| Chemokine Receptor Binding Heterocyclic Compounds With Enhanced Efficacy App 20090281308 - BRIDGER; Gary J. ; et al. | 2009-11-12 |
| Chemokine receptor binding heterocyclic compounds with enhanced efficacy Grant 7,550,484 - Bridger , et al. June 23, 2 | 2009-06-23 |
| Cxcr4 Chemokine Receptor Binding Compounds App 20080255197 - BRIDGER; Gary J. ; et al. | 2008-10-16 |
| CXCR4 chemokine receptor binding compounds Grant 7,291,631 - Bridger , et al. November 6, 2 | 2007-11-06 |
| Chemokine receptor binding heterocyclic compounds with enhanced efficacy App 20050059702 - Bridger, Gary J. ; et al. | 2005-03-17 |
| Pharmaceutical compositions comprising metal complexes App 20020049190 - Bridger, Gary J. ; et al. | 2002-04-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 